GA Therapy: A New Perspective – Eyetube
Daniel F. Martin, MD, explores the complexities of treating patients with GA, including the clinical trial dropout rate, complications, and further research that’s needed.
Daniel F. Martin, MD, explores the complexities of treating patients with GA, including the clinical trial dropout rate, complications, and further research that’s needed.
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, David A. Eichenbaum, MD, discusses the design of phase 3 trials…
Voretigene neparvovec (Luxturna, Spark Therapeutics, Inc.) was shown to be safe and effective in real-world settings.
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
Zarmeena Vendal, MD, describes the current landscape of laser therapy for glaucoma patients, including new technologies being developed.
The mission behind the optocosmetics company Èyes Are The Story
Healio brings you highlights from the Retina World Congress.
This quality improvement study characterizes diversity, equity, and inclusion content on ophthalmology fellowship program websites.
What conclusions can be drawn from a cross-trial comparison of randomized clinical trials assessing the safety and efficacy of anti-VEGF agents used in the treatment…
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Darius M. Moshfeghi, MD, discusses a retinopathy of prematurity scoring system…